RxDoctor Payments Data
★ My doctorsLook up a doctor →

Craig Patton

Psychiatric/Mental Health · Norman, OKNPI 1750008728

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 27.8% of the total.

$3,290in general payments, 2019–2025

Across 261 payments — averaging $12.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$915
  • AbbVie$434
  • Supernus Pharmaceuticals, Inc.$268
  • Johnson & Johnson$264
  • Corium, LLC$215
  • Alkermes, Inc.$200
  • plus $993 from 15 others

What the payments were for

  • Food & beverage$3,24199%
  • Education$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)102$915
AbbVie53$434
Supernus Pharmaceuticals, Inc.19$268
Johnson & Johnson18$264
Corium, LLC11$215
Alkermes, Inc.9$200
Otsuka America Pharmaceutical, Inc.6$142
Noven Therapeutics, LLC8$136
Ironshore Pharmaceuticals Inc.5$106
Axsome Therapeutics, Inc.5$96
Lundbeck LLC4$81
Neurocrine Biosciences, Inc.4$71
Collegium Pharmaceutical, Inc.3$64
Otsuka Pharmaceutical Development & Commercialization, Inc.2$50
Idorsia Pharmaceuticals US Inc3$48
E.r. Squibb & Sons, L.L.C.2$45
Takeda Pharmaceuticals U.S.A., Inc.2$41
Tris Pharma Inc2$38
Vanda Pharmaceuticals Inc.1$38
Avion Pharmaceuticals1$21
Vertical Pharmaceuticals, LLC1$16

How this compares

$3,290 in reported general payments places this provider in the 75th percentile of 231 psychiatric/mental health providers in Oklahoma.

See all psychiatric/mental health providers in Oklahoma →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clonazepam12$214

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Norman

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →